Article Versions Notes

Givi S, Lohnes BJ, Ebrahimi S, Riedel S, Khokhali S, Khan SA, Keller M, Wölfel C, Echchannaoui H, Bockamp E, et al. CRISPR/Cas9 TCR-Edited NKp30 CAR T Cells Exhibit Superior Anti-Tumor Immunity to B7H6-Expressing Leukemia and Melanoma. International Journal of Molecular Sciences. 2025; 26(17):8235. https://doi.org/10.3390/ijms26178235

Givi, Sedigheh, Benedikt J. Lohnes, Saber Ebrahimi, Sophie Riedel, Sneha Khokhali, Shamsul A. Khan, Maximilian Keller, Catherine Wölfel, Hakim Echchannaoui, Ernesto Bockamp, and et al. 2025. "CRISPR/Cas9 TCR-Edited NKp30 CAR T Cells Exhibit Superior Anti-Tumor Immunity to B7H6-Expressing Leukemia and Melanoma" International Journal of Molecular Sciences 26, no. 17: 8235. https://doi.org/10.3390/ijms26178235

Givi, S., Lohnes, B. J., Ebrahimi, S., Riedel, S., Khokhali, S., Khan, S. A., Keller, M., Wölfel, C., Echchannaoui, H., Bockamp, E., Andre, M. C., Abken, H., Theobald, M., & Hartwig, U. F. (2025). CRISPR/Cas9 TCR-Edited NKp30 CAR T Cells Exhibit Superior Anti-Tumor Immunity to B7H6-Expressing Leukemia and Melanoma. International Journal of Molecular Sciences, 26(17), 8235. https://doi.org/10.3390/ijms26178235